Abbott Articles
James Caggiano has joined Dendreon Corp
15 November 2004
Australian pharma alarm over govt generic pledge
15 November 2004
FDA OKs new form of Abbott's TriCor
15 November 2004
Vioxx withdrawal will not hurt COX-2s initially, says NOP survey
8 November 2004
Boeh Ingelheim files NDA for tipranavir
1 November 2004
US uninsured "pay 78% more than best Rx prices"
1 November 2004
Tokyo pharma stocks - week to October 18
25 October 2004
Tokyo pharma stocks - week to October 4
11 October 2004
Stock Commentary - Europe - week to Oct 4
11 October 2004
Tap appoints new executive vice president
11 October 2004
Waxman/Brown call for NIH investigation
11 October 2004
Euro AIDS activists call for Norvir price freeze
11 October 2004
Hugh Griffith named CEO of Bioenvision
20 September 2004
New analytical tool to evaluate accuracy of glucose monitoring
20 September 2004
Counterfeit Reductil found in UK
13 September 2004
Abbott donates $20K to Hepatitis Foundation Int
6 September 2004
New president of TAP Pharma named
6 September 2004
Sanofi-Aventis' Acomplia will have huge impact on obesity market
6 September 2004
Takeda on lookout for next blockbuster
23 August 2004
Experts warn on levothyroxine potency differences
16 August 2004
Boehringer Ingelheim's Mobic cleared for RA
16 August 2004
FDA OKs expanded use of Abbott's Humira
16 August 2004
US group welcomes WHO ARV de-listing
16 August 2004
Pharma again tops US charitable list
16 August 2004
Abbott files NDA for Zemplar capsules
9 August 2004
Australia plans to fast-track PBS drugs
9 August 2004
Australia Rx review plan published for comment
2 August 2004
Abbott and Deltanoid in renal research
26 July 2004
Oscient names three new VPs
26 July 2004
Neurobiological Tech buys Empire Pharma
26 July 2004
MSF calls for generic 2nd-line ARV combos
19 July 2004
Tokyo pharma stocks - week to july 12
19 July 2004
Abbott to submit NDA for Xinlay this year
19 July 2004
Ligand earns $1M milestone from TAP
19 July 2004
Abbott's 2nd-qtr 2004 sales rise 14%
19 July 2004
Abbott and Celera in cancer drug accord
12 July 2004
Jesus Leal named president of IVAX Labs
5 July 2004
Stock Commentary - New York
5 July 2004
Expanded use for TAP's Prevacid
5 July 2004
Tokyo pharma stocks - week to june 28
5 July 2004
PhRMA agenda "must be about helping people"
5 July 2004
Bentley gets Spanish OK for generic lansoprazole
28 June 2004
Ovation acquires CNS drug from Lundbeck
21 June 2004
US seniors' group sues pharma over imports
21 June 2004
US FDA raps Abbott over Norvir price claim
21 June 2004
Tokyo pharma stocks - week to June 14
14 June 2004
Abbott and PDL collaborate on antibodies
14 June 2004
Abbott buys rights to Aventis' tranolapril
14 June 2004
Insurer sues Abbott over Norvir price hike
7 June 2004
Stock Commentary - New York
31 May 2004
Weak core products sales at Yamanouchi
31 May 2004
CAT sues Abbott over Humira royalties dispute
24 May 2004
CAT sees net loss slip 4.3% for first half
24 May 2004
Generics' major role in new French Rx policy
24 May 2004
Stock Commentary - New York
26 April 2004
Former Abbott president joins Baxter
26 April 2004
Canada: patient groups call for import ban
26 April 2004
Tokyo pharma stocks - week to April 19
26 April 2004
Orion/Abbott expand levosimendan accord
26 April 2004
Stock Commentary - New York
19 April 2004
Tokyo pharma stocks - week to April 12
19 April 2004
Abbott sees 13.9% rise in sales for 1st-qtr 2004
19 April 2004
Ovation gains two CNS drugs from Aventis
19 April 2004
Sepracor amends Xopenex promotion deal with Ross
29 March 2004
Abbott's rare win over generics firm
29 March 2004
Abbott wins Depakote patent sut against TorPharm
22 March 2004
US approval for Abbott/Seradyn diabetes test
15 March 2004
Abbott and EUROPROTEOME sign diagnostic deal
8 March 2004
Abbott forecasts 2004 acquisitions charges
1 March 2004
Compugen and Abbott extend deal
23 February 2004
Stock Commentary - Europe
23 February 2004
Once-daily Kaletra shows promise
23 February 2004
Abbott's Humira shows promise for psoriasis
23 February 2004
Abbott under attack over Norvir price hike
16 February 2004
Karo Bio full-year 2003 turnover down 52.1%
16 February 2004
Abbott, B-MS, GSK lead growing HIV Rx mkt
16 February 2004
Parke-Davis case
16 February 2004
Abbott Labs names Richar Ashley exec VP, corporate development
9 February 2004
Australia "vigilant" over Internet drug trades
9 February 2004
Abbott Labs names James White director of Washington DC office
2 February 2004
Abbott reports sharp rise in 4-qtr profit
26 January 2004
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Is the diabetes market facing a blockbuster-free future?
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
